Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777-Reference-Cited by-同舟云学术

Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777

Published:2019-11-26 Issue:4 Volume:38 Page:902-910
ISSN:0736-0266
Container-title:Journal of Orthopaedic Research
language:en
Short-container-title:J. Orthop. Res.

Author:

Thanindratarn Pichaya¹²^ORCID,Li Xiaoyang¹³,Dean Dylan C.¹,Nelson Scott D.⁴,Hornicek Francis J.¹,Duan Zhenfeng¹^ORCID

Affiliation:

1. Department of Orthopedic Surgery, Sarcoma Biology Laboratory, David Geffen School of MedicineUniversity of CaliforniaLos Angeles California

2. Department of Orthopedic Surgery, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical ScienceChulabhorn Royal AcademyBangkok Thailand

3. Department of Orthopedic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijing China

4. Department of PathologyUniversity of CaliforniaLos Angeles California

Funder

Sarcoma Foundation of America

Institut National Du Cancer

Publisher

Wiley

Subject

Orthopedics and Sports Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jor.24528

Reference23 articles.

1. Noone AM Howlader N Krapcho M et al. 2018. SEER Cancer statistics review. 1975‐2015. Bethesda MD: National Cancer Institute https://seercancergov/csr/1975_2015/

2. Cancer statistics, 2019

3. Current and future therapeutic approaches for osteosarcoma

4. Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG-782 and INT0133-A Report From the Children's Oncology Group Bone Tumor Committee

5. Prognostic Factors in High-Grade Osteosarcoma of the Extremities or Trunk: An Analysis of 1,702 Patients Treated on Neoadjuvant Cooperative Osteosarcoma Study Group Protocols

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and barriers to rapid establishment of patient-derived primary osteosarcoma cell lines in clinical management;iScience;2024-09

2. Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma;Heliyon;2024-01

3. Enhanced Biomimetics of Three-Dimensional Osteosarcoma Models: A Scoping Review;Cancers;2023-12-28

4. Correction to “Establishment and characterization of a recurrent osteosarcoma cell line: OSA 1777”;Journal of Orthopaedic Research;2023-11-28

5. Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine;Biomolecules;2023-09-07